You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 6, February 14, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  This Week in JAMA
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

This Week in JAMA

JAMA. 2001;285:695.

Alzheimer Disease in Yoruba and African Americans

Environmental as well as genetic factors are likely to influence the risk of Alzheimer disease. Hendrie and colleagues (SEE ARTICLE) compared the incidence rates of dementia and Alzheimer disease among Yoruba residents of Ibadan, Nigeria, with rates among African American residents of Indianapolis, Ind, after 2 and 5 years of follow-up. The age-standardized annual incidence rates for both dementia and Alzheimer disease were significantly lower among Yoruba in Ibadan than among African Americans living in Indianapolis. In an editorial, Farrer (SEE ARTICLE) suggests that identification of distinct genetic and environmental risk factor profiles for Alzheimer disease might eventually lead to therapies tailored for specific risk groups.


Oseltamivir Prevents Influenza in Household Contacts

In prior studies, oseltamivir, a selective oral inhibitor of influenza neuraminidase, has been shown to be efficacious for treatment of influenza and for prevention during an outbreak. To study the efficacy of oseltamivir in preventing the spread of influenza to household contacts of influenza-infected individuals, Welliver and colleagues randomly assigned household contacts by household cluster to receive oseltamivir or placebo once daily for 7 days within 48 hours of symptom onset in the infected household member. The overall protective efficacy of oseltamivir against clinical influenza was 89% for household contacts and 84% for households of influenza-infected individuals.

(SEE ARTICLE)


Survival and Reproduction in Males With Birth Defects

Few data are available on the risk of birth defects among offspring of fathers with birth defects. Lie and colleagues followed up a cohort of males born between 1967 and 1982 for survival rates through 1992 and for reproductive outcomes through 1998. Compared with males without birth defects, males with birth defects had higher mortality through infancy and childhood and were 28% less likely to father a child. The total risk of birth defects was 5.1% among offspring of males with birth defects and 2.1% among offspring of males without birth defects.

(SEE ARTICLE)


Rapid Diagnostic Tests to Exclude Pulmonary Embolism

In acute care settings, evaluation of patients with suspected pulmonary embolism using pulmonary vascular imaging is often time-consuming and costly. Kline and colleagues studied whether the use of 2 minimally invasive bedside tests—whole-blood agglutination D-dimer assay and volumetric capnometry with PaCO2 to measure alveolar dead-space fraction—could exclude the diagnosis of pulmonary embolism. Among 380 emergency department patients with suspected acute pulmonary embolism, pulmonary embolism was diagnosed in 64 patients based on standard criteria using radiographic examinations. Sixty-three of the 64 had either an abnormal D-dimer concentration or alveolar dead-space fraction or both (sensitivity, 98.4%), and 163 of the 316 patients without pulmonary embolism had normal results for both tests (specificity, 51.6%).

(SEE ARTICLE)


Fruit and Vegetable Consumption and Breast Cancer Risk

Most of the studies supporting an association between fruit and vegetable consumption and a reduced risk of breast cancer have been case-control studies, which are subject to recall and selection bias. In this analysis, Smith-Warner and colleagues (SEE ARTICLE) pooled data from 8 prospective cohort studies on breast cancer risk and dietary intake. Fruit, fruit juice, total fruit, total vegetable, and total fruit and vegetable intakes were not associated with reduced breast cancer risk when modeled as continuous variables, and breast cancer risk was only 3% to 9% lower in women in the highest decile of fruit or vegetable consumption compared with the lowest decile. In an editorial, Slattery (SEE ARTICLE) discusses limitations of studies of diet and cancer risk and comments on current National Cancer Institute recommendations for fruit and vegetable consumption.


A Piece of My Mind

"Mrs DeFranco was a veteran of many grand rounds and knew what to expect." From "Tactile."

(SEE ARTICLE)


Contempo Updates

Analysis of data from recent studies on mother-to-infant transmission of HIV suggests that about half of transmissions occur during the days just before delivery and another third occur during labor and delivery.

(SEE ARTICLE)


Medical News & Perspectives

The Ethical, Legal, and Social Implications program of the National Human Genome Research Institute marked its 10th birthday with a conference aimed at fitting the new knowledge of genetics into the reality of 21st-century life.

(SEE ARTICLE)


Surrogate End Points in AIDS Clinical Trials

In AIDS clinical trials, a regimen termination end point—the time to the first occurrence of any protocol-specified event that leads to cessation of the assigned treatment regimen—measures important effects of treatment not captured by plasma HIV RNA levels.

(SEE ARTICLE)


Consensus Statement on Osteoporosis

Report from the National Institutes of Health Consensus Development Panel on the prevention, diagnosis, and treatment of osteoporosis.

(SEE ARTICLE)


MSJAMA

The impact of the Internet on patient advocacy and support, medical education, health law and ethics, and clinical practice.

(SEE ARTICLE)


JAMA Patient Page

For your patients: Information about pulmonary embolism.

(SEE ARTICLE)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.